Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rifaquat Musaffa Rahman, M.D.

Concepts (142)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Glioblastoma25202434813.240 Why?
Brain Neoplasms29202488632.990 Why?
Glioma6202334010.880 Why?
Controlled Clinical Trials as Topic120211870.760 Why?
Lymphopenia120222850.730 Why?
Cranial Irradiation220204010.660 Why?
Research Design8202359870.640 Why?
Medical Oncology4202322650.570 Why?
Central Nervous System Neoplasms220228950.560 Why?
Antineoplastic Agents, Alkylating120206270.540 Why?
Clinical Trials, Phase III as Topic120198410.520 Why?
Patient Care120216400.510 Why?
Angiogenesis Inhibitors5201720380.500 Why?
Neurology120217630.450 Why?
Radiation Injuries1202011800.430 Why?
Meningioma1202112090.430 Why?
Neoplasm Recurrence, Local7202392390.430 Why?
Meningeal Neoplasms1202112410.420 Why?
Proportional Hazards Models52023123540.420 Why?
Rectal Neoplasms1202112060.400 Why?
Randomized Controlled Trials as Topic5202399590.360 Why?
Immunotherapy5202344450.320 Why?
Radiosurgery3202313290.320 Why?
Information Dissemination3202110990.310 Why?
Salvage Therapy1201412750.300 Why?
Neoplasms32023216830.240 Why?
Clinical Trials as Topic5202379130.230 Why?
Models, Biological1202095830.230 Why?
Humans4720247443430.220 Why?
Antineoplastic Agents32021136950.220 Why?
Random Allocation2202324290.200 Why?
Dacarbazine220225660.200 Why?
Survival Analysis62021102520.190 Why?
Medical Futility120221270.190 Why?
Pandemics1202183880.190 Why?
Melanoma1201855100.170 Why?
Drug Resistance, Neoplasm1201451720.170 Why?
Drugs, Investigational120212140.160 Why?
Decision Making3202338870.160 Why?
Combined Modality Therapy3202086420.160 Why?
Prostatic Neoplasms12021111240.160 Why?
SEER Program1202215080.150 Why?
Standard of Care120215640.150 Why?
Cancer Vaccines1202310230.140 Why?
Comparative Effectiveness Research120216810.130 Why?
Retrospective Studies132023774490.130 Why?
Hospitalization12015102620.130 Why?
Gene Dosage1202012520.130 Why?
Bayes Theorem1202323090.130 Why?
Tumor Burden3201819150.130 Why?
Magnetic Resonance Imaging92023354210.130 Why?
Lomustine12014590.120 Why?
Kaplan-Meier Estimate3202165380.120 Why?
Carmustine120141370.120 Why?
Data Collection1202333410.120 Why?
Disease Progression52018132840.120 Why?
Infection Control120219660.110 Why?
Antineoplastic Combined Chemotherapy Protocols12014115240.110 Why?
Breast Neoplasms12021208220.110 Why?
Treatment Outcome82021631140.110 Why?
Carcinoma, Non-Small-Cell Lung2202152210.100 Why?
Prognosis62023290630.100 Why?
Astrocytoma120157900.100 Why?
Societies, Medical1202337430.100 Why?
Aged, 80 and over62020577760.090 Why?
Female1520223801940.090 Why?
Sarcoma1202218970.090 Why?
Adult1320242140550.090 Why?
Patient Selection2202142150.090 Why?
Aged920201632800.090 Why?
Middle Aged1220202133830.090 Why?
Male1520213501180.090 Why?
Young Adult82018564300.080 Why?
Electronic Health Records2202344680.080 Why?
Patient Participation1201814570.080 Why?
Risk1202196870.080 Why?
Reproducibility of Results22023199050.080 Why?
Computational Biology1202035210.080 Why?
Molecular Targeted Therapy1201827270.070 Why?
Radiology1202121000.070 Why?
Survival Rate32017127880.070 Why?
Lung Neoplasms22021131020.070 Why?
Diffusion Magnetic Resonance Imaging2201627370.070 Why?
Neoplasm Proteins1201837030.070 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors1202132550.070 Why?
Cues120108730.060 Why?
Mutation42024297860.060 Why?
Head and Neck Neoplasms1201827340.060 Why?
Algorithms22022138810.060 Why?
Photic Stimulation1201020250.060 Why?
Reaction Time1201020970.060 Why?
Carcinoma, Squamous Cell1201840340.050 Why?
Incidence22020209470.050 Why?
Memory1201021740.050 Why?
Students1201016540.050 Why?
Ribonuclease III120222750.050 Why?
Disease-Free Survival3201668950.040 Why?
Neoplasm Staging12014110310.040 Why?
Risk Assessment12021233380.040 Why?
DEAD-box RNA Helicases120223750.040 Why?
Pathology, Molecular120223260.040 Why?
DNA Helicases120248590.040 Why?
Follow-Up Studies22017390500.040 Why?
Necrosis1202016430.030 Why?
Probability1202225050.030 Why?
United States12022698720.030 Why?
Substance-Related Disorders1201042580.030 Why?
Retreatment120156100.030 Why?
Phantoms, Imaging1202224800.030 Why?
Immune Tolerance1202222580.030 Why?
Clinical Trials, Phase II as Topic120156290.030 Why?
Cell Cycle Proteins1202434620.030 Why?
Dendritic Cells1202327250.030 Why?
Radiation Dosage1202119280.030 Why?
Area Under Curve1201516540.020 Why?
Seizures1202428590.020 Why?
Tumor Microenvironment1202335860.020 Why?
High-Throughput Nucleotide Sequencing1202235970.020 Why?
Echo-Planar Imaging120146590.020 Why?
Lymphatic Metastasis1201729240.020 Why?
Observer Variation1201525930.020 Why?
Computer Simulation1202361960.020 Why?
Nuclear Proteins1202458530.020 Why?
Models, Statistical1202351020.020 Why?
Risk Factors12015722900.020 Why?
Genomics1202457200.020 Why?
ROC Curve1201535270.020 Why?
Neoplasm Metastasis1201848510.020 Why?
Marijuana Smoking120102530.020 Why?
Databases, Factual1202177290.020 Why?
Prospective Studies22021532880.020 Why?
Contrast Media1201753000.020 Why?
Transcription Factors12024122080.010 Why?
Image Interpretation, Computer-Assisted1201633270.010 Why?
Image Processing, Computer-Assisted1201789490.010 Why?
Time Factors12021400750.010 Why?
Predictive Value of Tests12014150760.010 Why?
Alcohol Drinking1201039660.010 Why?
Mice12023811830.010 Why?
Brain12022263850.010 Why?
Child12022777090.010 Why?
Animals120231687570.010 Why?
Rahman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (142)
Explore
_
Co-Authors (72)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.